Physician profile
James E Southerland
NPI 1568433407
$533.85
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $55.88 · 2021: $218 · 2022: $42.56 · 2023: $75.60 · 2024: $25.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $100.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $168.27 | 2019-2022 | |
| Lilly USA, LLC | $86.05 | 2021-2023 | Mounjaro |
| Ultragenyx Pharmaceutical INC. | $63.51 | 2019-2021 | |
| Astellas Pharma US INC | $43.78 | 2023-2024 | Veozah, Myrbetriq |
| Abbott Laboratories | $42.75 | 2021-2023 | Freestyle Libre 2 |
| Emmaus Medical, INC. | $28.63 | 2021 | |
| Evofem Biosciences, INC. | $24.38 | 2022 | |
| Philips North America LLC | $23.82 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.47 | 2023 | Xifaxan |
| Kaleo, INC. | $18.05 | 2019 | |
| Amgen INC. | $14.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Southerland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.